23-Feb-2026
Zimmer Biomet declares $0.24 dividend
Seeking Alpha News (Mon, 23-Feb 7:04 AM ET)
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2026
PRNewswire (Mon, 23-Feb 7:00 AM ET)
BTIG Sticks to Its Buy Rating for Zimmer Biomet Holdings (ZBH)
TipRanks (Fri, 20-Feb 11:55 AM ET)
Zimmer Biomet’s New Stemless Shoulder Study Signals Strategic Push in Joint Reconstruction
TipRanks (Thu, 19-Feb 11:33 AM ET)
PRNewswire (Wed, 18-Feb 9:05 AM ET)
Market Chameleon (Tue, 10-Feb 4:19 AM ET)
Zimmer Biomet Announces Fourth Quarter and Full-Year 2025 Financial Results
PRNewswire (Tue, 10-Feb 6:30 AM ET)
PRNewswire (Wed, 4-Feb 12:33 PM ET)
Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2025 Financial Results
PRNewswire (Thu, 15-Jan 7:30 AM ET)
Zimmer Biomet to Present at the 44th Annual J.P. Morgan Healthcare Conference
PRNewswire (Mon, 22-Dec 7:30 AM ET)
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Zimmer Biomet Holdings trades on the NYSE stock market under the symbol ZBH.
As of February 23, 2026, ZBH stock price climbed to $99.46 with 1,471,847 million shares trading.
ZBH has a beta of 0.59, meaning it tends to be less sensitive to market movements. ZBH has a correlation of 0.11 to the broad based SPY ETF.
ZBH has a market cap of $19.70 billion. This is considered a Large Cap stock.
Last quarter Zimmer Biomet Holdings reported $2 billion in Revenue and $2.42 earnings per share. This beat revenue expectation by $30 million and exceeded earnings estimates by $.03.
In the last 3 years, ZBH traded as high as $149.25 and as low as $84.59.
The top ETF exchange traded funds that ZBH belongs to (by Net Assets): VTI, VOO, VO, MOAT, IVV.
ZBH has underperformed the market in the last year with a return of -3.1%, while SPY returned +13.0%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ZBH shares. However, ZBH has outperformed the market in the last 3 month and 2 week periods, returning +11.9% and +10.6%, while SPY returned +4.9% and -1.2%, respectively. This indicates ZBH has been having a stronger performance recently.
ZBH support price is $97.34 and resistance is $100.16 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ZBH shares will trade within this expected range on the day.